- Role
- Country
- Date of registration
- Address
EUDAMED last updated this device on Aug 8, 2022
B-16438153816246FI-MF-000001479Primary placement in Finland; available across 18 countries total.
| Country | On market since | Until |
|---|---|---|
| FinlandPrimary placement | Oct 29, 2015 | May 26, 2027 |
| Czechia | Oct 29, 2015 | May 26, 2027 |
| Germany | Oct 29, 2015 | May 26, 2027 |
| Estonia | Oct 29, 2015 | May 26, 2027 |
| EL | Oct 29, 2015 | May 26, 2027 |
| Spain | Oct 29, 2015 | May 26, 2027 |
| France | Oct 29, 2015 | May 26, 2027 |
| Hungary | Oct 29, 2015 | May 26, 2027 |
| Ireland | Oct 29, 2015 | May 26, 2027 |
| Italy | Oct 29, 2015 | May 26, 2027 |
| Lithuania | Oct 29, 2015 | May 26, 2027 |
| Latvia | Oct 29, 2015 | May 26, 2027 |
| Malta | Oct 29, 2015 | May 26, 2027 |
| Poland | Oct 29, 2015 | May 26, 2027 |
| Portugal | Oct 29, 2015 | May 26, 2027 |
| Sweden | Oct 29, 2015 | May 26, 2027 |
| Slovakia | Oct 29, 2015 | May 26, 2027 |
| XI | Oct 29, 2015 | May 26, 2027 |
W0102090106COCAINE + COCAINE METABOLITESCertificate health across this manufacturer's portfolio.
HX 1070846-1Supplemented